NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed an agreement making clinical services provider Best Med Opinion the exclusive distributor of Interpace’s cancer molecular diagnostics in Israel.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.